Managing Trace Elements in Parenteral Nutrition
A new website providing educational content and treatment guidelines
Dedicated to Alleviating Drug Shortages
We are committed to collaborating with the FDA to prevent or mitigate drug shortages that impact the health of patients.
Check Product Availability
Updated March 28, 2023
HydrALAZINE Hydrochloride
- 20 mg/mL | 1 mL Single Dose Vial
- Shelf Pack — 25
Papaverine HCL
- 30 mg/mL | 2 mL Single Dose Vial
- Shelf Pack — 25
Zinc Sulfate
- 5 mg/mL | 5 mL Pharmacy Bulk Package Vial
- Shelf Pack — 25
News Center
American Regent introduces FDA-approved Epinephrine Injection, USP
Melville, NY – March 23, 2023: American Regent announces the launch of sulfite-free Epinephrine Injection, USP.
HBT Labs, Inc. to Join American Regent, Inc
Shirley, NY – American Regent, Inc., a U.S. manufacturer of pharmaceuticals for human and veterinary use with manufacturing sites in New York and Ohio, today announced it acquired HBT Labs, Inc. based in California.
American Regent Launches FDA-Approved Atropine Sulfate Injection, USP
Melville, NY – August 9, 2022: American Regent, Inc. has announced the launch of Atropine Sulfate Injection, USP, a longstanding injectable medication, now with FDA approval.